![]() | Baha M Sibaı̈From the Department of Obstetrics and Gynecology (A.T.T., W.W.A.), the Center for Women’s Reproductive Health (A.T.T., J.M.S., N.A., S.O., G.R.C., W.W.A.), the Department of ... |
KOL Resume for Baha M Sibaı̈
Year | |
---|---|
2022 | From the Department of Obstetrics and Gynecology (A.T.T., W.W.A.), the Center for Women’s Reproductive Health (A.T.T., J.M.S., N.A., S.O., G.R.C., W.W.A.), the Department of Biostatistics (J.M.S., G.R.C.), the Division of Neonatology, Department of Pediatrics (N.A.), and the Division of Cardiovascular Disease, Department of Medicine (S.O.), University of Alabama, Birmingham; the Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill (K.B.), and the Department of Obstetrics... Division of Maternal‐Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA Obstetrics & Gynecology, University of Texas Health Sciences Center at Houston, Houston, United States |
2021 | Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin St., Ste. 3.264, Houston, TX 77030. 1Department of Obstetrics, Gynecology and Reproductive Sciences McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX Department of Obstetrics and Gynecology, University of Texas—Houston, Houston, Texas |
2020 | Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School-UTHealth, 6431 Fannin, Houston, TX 77030 USA University of Texas Health Sciences Center at Houston, Houston, TX. |
2019 | Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston. University of Texas–Houston, Houston, TX |
2018 | Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Texas Medical Branch, Galveston, and the Department of Obstetrics, Gynecology and Reproductive Sciences, UT Health, University of Texas Medical School at Houston, Houston, Texas; and the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania. University of Texas – Houston, Houston, TX (B.S.) |
2017 | Dept. OB/GYN McGovern Medical School at UTHealth, Houston, TX McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas |
2016 | Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, UT Health-University of Texas Medical School at Houston, Texas |
2015 | Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Health, University of Texas, Houston, TX From the Departments of Biochemistry and Molecular Biology (T.I., W.W., N.F.P., A.S., R.E.K., Y.X.) and Obstetrics, Gynecology, and Reproductive Sciences (S.C.B., B.M.S.), The University of Texas Medical School at Houston; Graduate School of Biomedical Sciences, Graduate Program in Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston (N.F.P., R.E.K., Y.X.); Department of Nephrology, Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China (W.W., Y.X.); and Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan (T.I.). Departments of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee |
Baha M Sibaı̈: Influence Statistics
Concept | World rank |
---|---|
37 40 weeks | #1 |
lidocaine protein preeclampsia | #1 |
antiangiogenic profile | #1 |
previous cesarean prom | #1 |
women mild | #1 |
streptococcus respondents | #1 |
hypertensionpreeclampsia | #1 |
low platelet syndrome | #1 |
admission cesarean delivery | #1 |
symptom preeclampsia | #1 |
preeclampsia randomized | #1 |
eclampsia convulsions | #1 |
nonpreventable eclampsia | #1 |
sga minor alleles | #1 |
severe hypertension proteinuria | #1 |
eclamptic convulsions | #1 |
hemolysis elevated | #1 |
≥39 weeks women | #1 |
maternalperinatal outcome | #1 |
incidence multifetal gestations | #1 |
10 management | #1 |
preeclampsia reported rate | #1 |
sipsf | #1 |
partial compliance prevention | #1 |
study 11 | #1 |
preeclampsia sflt1 level | #1 |
management liver hematoma | #1 |
dams inos | #1 |
respondents cesarean | #1 |
epidural anesthesia frequencies | #1 |
pregnancy activetreatment | #1 |
women severe preeclampsia | #1 |
gestational age dependent | #1 |
13 university centers | #1 |
midtrimester preterm birth | #1 |
receiving magnesium | #1 |
labor sbp | #1 |
ghtn gdm | #1 |
16317 women | #1 |
uterine rupture probability | #1 |
634733 | #1 |
preeclamptic odds ratio | #1 |
periportal hemorrhage | #1 |
stillborn fetus admission | #1 |
prevention eclamptic seizures | #1 |
6 am8 | #1 |
enos offspring wt | #1 |
women antepartum eclampsia | #1 |
correlation bleeding time | #1 |
abruptio placentae preeclampsia | #1 |
Open the FULL List in Excel | |
Prominent publications by Baha M Sibaı̈
Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery
[ PUBLICATION ]
BACKGROUND: The proportion of women who attempt vaginal delivery after prior cesarean delivery has decreased largely because of concern about safety. The absolute and relative risks associated with a trial of labor in women with a history of cesarean delivery, as compared with elective repeated cesarean delivery without labor, are uncertain.
METHODS: We conducted a prospective four-year observational study of all women with a singleton gestation and a prior cesarean delivery at 19 ...
Known for Labor Women | Cesarean Delivery | Perinatal Outcomes | Elective Repeated | Hypoxicischemic Encephalopathy |
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia
[ PUBLICATION ]
OBJECTIVE: The current literature emphasizes increased risk of adverse outcomes in the presence of proteinuria and hypertension. The objective of this study was to compare the frequency of adverse fetal outcomes in women who developed hypertensive disorders with or without proteinuria.
STUDY DESIGN: The study design was a secondary analysis of data from women who had preeclampsia in a previous pregnancy (n = 598) who were enrolled in a multicenter trial of aspirin for the prevention of ...
Known for Mild Preeclampsia | Women Gestational Hypertension | Perinatal Outcomes | Preterm Delivery | Severe Gestational |
Trial of Labor or Repeat Cesarean Delivery in Women With Morbid Obesity and Previous Cesarean Delivery
[ PUBLICATION ]
OBJECTIVE: Assess effects of body mass index (BMI) on trial of labor after previous cesarean delivery and determine whether morbidly obese women have greater maternal and perinatal morbidity with trial of labor compared with elective repeat cesarean delivery.
METHODS: Secondary analysis from a prospective observational study included all term singletons undergoing trial of labor after previous cesarean delivery. Body mass index groups were as follows: normal 18.5-24.9, overweight ...
Known for Previous Cesarean Delivery | Trial Labor | Repeat Cesarean | Morbid Obesity | Obese Women |
Risk of Uterine Rupture With a Trial of Labor in Women With Multiple and Single Prior Cesarean Delivery
[ PUBLICATION ]
OBJECTIVE: To determine whether the risk for uterine rupture is increased in women attempting vaginal birth after multiple cesarean deliveries.
METHODS: We conducted a prospective multicenter observational study of women with prior cesarean delivery undergoing trial of labor and elective repeat operation. Maternal and perinatal outcomes were compared among women attempting vaginal birth after multiple cesarean deliveries and those with a single prior cesarean delivery. We also compared ...
Known for Uterine Rupture | Prior Cesarean | Labor Women | Vaginal Birth | Maternal Morbidity |
Elevated concentrations of interleukin-6 (IL-6), C-reactive protein (CRP), and matrix metalloproteinase-9 (MMP-9) in fetal and neonatal compartments have been associated with an increased risk for preterm birth (PTB) and/or neonatal morbidity. The purpose of this study was to determine if the maternal serum concentration of IL-6, CRP, and MMP-9 in women at risk for PTB, who are not in labor and have intact membranes, are associated with an increased risk for PTB <32 weeks and/or neonatal ...
Known for Maternal Serum | Adverse Neonatal Outcomes | Preterm Birth | Il6 Crp | Reactive Protein |
The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women
[ PUBLICATION ]
OBJECTIVE: The study's aim was to determine whether healthy nulliparous women with abnormal glucose tolerance during pregnancy are at increased risk for development of pregnancy-associated hypertension or preeclampsia.
STUDY DESIGN: A series of 4589 healthy nulliparous women from 5 university centers were evaluated prospectively to determine whether calcium supplementation would prevent preeclampsia. Pregnancy-associated hypertension was a diastolic blood pressure > or = 90 mm Hg on 2 ...
Known for Hypertensive Disorders | Glucose Tolerance | Preeclampsia Women | Pregnancy Increased Risk | Gestational Diabetes Mellitus |
OBJECTIVE: The purpose of this study was to compare the rates of indicated and spontaneous preterm delivery among women with chronic hypertension or pregestational diabetes mellitus with the rates among healthy women.
STUDY DESIGN: This was a secondary analysis of data from healthy women with singleton gestations enrolled in a prospective observational study for prediction of preterm delivery (control group, n = 2738), women with pregestational diabetes mellitus requiring insulin therapy ...
Known for Preterm Delivery | Diabetes Mellitus | Chronic Hypertension | 95 Confidence Interval | Cardiovascular Pregnancy |
BACKGROUND: Because of increased rates of respiratory complications, elective cesarean delivery is discouraged before 39 weeks of gestation unless there is evidence of fetal lung maturity. We assessed associations between elective cesarean delivery at term (37 weeks of gestation or longer) but before 39 weeks of gestation and neonatal outcomes.
METHODS: We studied a cohort of consecutive patients undergoing repeat cesarean sections performed at 19 centers of the Eunice Kennedy Shriver ...
Known for Repeat Cesarean | Neonatal Outcomes | 39 Weeks Gestation | 37 Weeks | Newborn Sepsis |
Failure of Metronidazole to Prevent Preterm Delivery among Pregnant Women with Asymptomatic Trichomonas vaginalis Infection
[ PUBLICATION ]
BACKGROUND: Infection with Trichomonas vaginalis during pregnancy has been associated with preterm delivery. It is uncertain whether treatment of asymptomatic trichomoniasis in pregnant women reduces the occurrence of preterm delivery.
METHODS: We screened pregnant women for trichomoniasis by culture of vaginal secretions. We randomly assigned 617 women with asymptomatic trichomoniasis who were 16 to 23 weeks pregnant to receive two 2-g doses of metronidazole (320 women) or placebo (297 ...
Known for Pregnant Women | Preterm Delivery | Asymptomatic Trichomonas | Vaginalis Infection | Newborn Infant |
BACKGROUND: Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia. Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women.
METHODS: We performed a nested case-control study of ...
Known for Soluble Endoglin | Preeclampsia Women | Circulating Antiangiogenic | Newborn Infant | 37 Weeks |
Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother
[ PUBLICATION ]
Minimal data exist concerning the relationship between hypertensive pregnancy disorders and various subsequent cardiovascular events and the effect of type 2 diabetes mellitus on these. In a registry-based cohort study, we identified women delivering in Denmark from 1978 to 2007 with a first singleton (n=782 287) and 2 first consecutive singleton deliveries (n=536 419). The exposures were gestational hypertension and mild and severe preeclampsia. We adjusted for preterm delivery, small ...
Known for 2 Diabetes | Hypertensive Pregnancy Disorders | Subsequent Hypertension | Preeclampsia Pregnancy | Mellitus Type |
BACKGROUND: Whether low-dose aspirin prevents preeclampsia is unclear. It is not recommended as prophylaxis in women at low risk for preeclampsia but may reduce the incidence of the disease in women at high risk.
METHODS: We conducted a double-blind, randomized, placebo-controlled trial in four groups of pregnant women at high risk for preeclampsia, including 471 women with pregestational insulin-treated diabetes mellitus, 774 women with chronic hypertension, 688 women with multifetal ...
Known for Risk Preeclampsia | Aspirin Placebo | Pregnancy Women | Multifetal Gestations | Chronic Hypertension |
OBJECTIVES: This study was designed to evaluate the efficacy and safety of the oxytocin receptor antagonist atosiban in the treatment of preterm labor.
STUDY DESIGN: A multicenter, double-blind, placebo-controlled trial with tocolytic rescue was designed. Five hundred thirty-one patients were randomized to receive, and 501 received, either intravenous atosiban (n = 246) or placebo (n = 255), followed by subcutaneous maintenance with the assigned agent. Standard tocolytics as rescue ...
Known for Preterm Labor | Atosiban Treatment | Gestational Age | Oxytocin Receptor | 28 Weeks |
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
[ PUBLICATION ]
BACKGROUND: Bacterial vaginosis has been associated with preterm birth. In clinical trials, the treatment of bacterial vaginosis in pregnant women who previously had a preterm delivery reduced the risk of recurrence.
METHODS: To determine whether treating women in a general obstetrical population who have asymptomatic bacterial vaginosis (as diagnosed on the basis of vaginal Gram's staining and pH) prevents preterm delivery, we randomly assigned 1953 women who were 16 to less than 24 ...
Known for Preterm Delivery | Bacterial Vaginosis | Pregnant Women | Treatment Metronidazole | Obstetric Labor |
BACKGROUND: The cause of preeclampsia remains unclear. Limited data suggest that excess circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor (PlGF) and vascular endothelial growth factor (VEGF), may have a pathogenic role.
METHODS: We performed a nested case-control study within the Calcium for Preeclampsia Prevention trial, which involved healthy nulliparous women. Each woman with preeclampsia was matched to one normotensive control. A total of ...
Known for Angiogenic Factors | Preeclampsia Onset | Plgf Levels Women | Sflt1 Level | Milliliter Controls |
Key People For Severe Preeclampsia
Baha M Sibaı̈:Expert Impact
Concepts for whichBaha M Sibaı̈has direct influence:Severe preeclampsia, Gestational age, Cesarean delivery, Chronic hypertension, Preterm delivery, Expectant management, Preterm birth, Magnesium sulfate.
Baha M Sibaı̈:KOL impact
Concepts related to the work of other authors for whichfor which Baha M Sibaı̈ has influence:Preterm birth, Pregnant women, Hellp syndrome, Gestational age, Hypertensive disorders, Cesarean delivery, Blood pressure.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |